Condition
Aminoglycoside Toxicity
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06500975Not ApplicableRecruiting
Long Term Outcomes After Vestibular Implantation
NCT06226441Not ApplicableRecruiting
Aminoglycoside Administration in Septic Patients
NCT05533593CompletedPrimary
Risk Factors and Machine Learning Model for Aminoglycines Related Acute Kidney Injury
NCT05847556Not ApplicableUnknownPrimary
Video Game Hearing Tests for Remote Monitoring of Ototoxicity
Showing all 4 trials